Abbott Labs Stung by Foreign Exchange Rate
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but missed slightly on revenues. The drug maker reported adjusted diluted ...Read Full Story »







